Gene · 3759
Papers3,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 3,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Editorial: Improving medical diagnosis in rare diseases. | Front Genet | 2022 | 36147485 | PubTator, text mining | PubMed |
| Grapefruit Flavonoid Naringenin Sex-Dependently Modulates Action Potential in an In Silico Human Ventricular Cardiomyocyte Model. | Antioxidants (Basel) | 2022 | 36139745 | PubTator, text mining | PubMed |
| Cerebral Seizures in an Adolescent with Jervell and Lange-Nielsen Syndrome: It May Not Be Epilepsy. | Clin Pract | 2022 | 36136864 | PubTator, text mining | PubMed |
| Molecular mechanisms, physiological roles, and therapeutic implications of ion fluxes in bone cells: Emphasis on the cation-Cl- cotransporters. | J Cell Physiol | 2022 | 36125923 | PubTator, text mining | PubMed |
| Tumor-associated macrophages are shaped by intratumoral high potassium via Kir2.1. | Cell Metab | 2022 | 36103895 | PubTator, text mining | PubMed |
| KCNJ14 knockdown significantly inhibited the proliferation and migration of colorectal cells. | BMC Med Genomics | 2022 | 36100894 | PubTator, text mining | PubMed |
| Case report: Mexiletine suppresses ventricular arrhythmias in Andersen-Tawil syndrome. | Front Cardiovasc Med | 2022 | 36093155 | PubTator, text mining | PubMed |
| Non-coding RNAs in cancer therapy-induced cardiotoxicity: Mechanisms, biomarkers, and treatments. | Front Cardiovasc Med | 2022 | 36082126 | PubTator, text mining | PubMed |
| Identification of recurrent variants implicated in disease in bicuspid aortic valve patients through whole-exome sequencing. | Hum Genomics | 2022 | 36071494 | PubTator, text mining | PubMed |
| Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside. | Front Cardiovasc Med | 2022 | 36061538 | PubTator, text mining | PubMed |
| Hypoxia inhibits the cardiac I K1 current through SUMO targeting Kir2.1 activation by PIP2. | iScience | 2022 | 36060074 | PubTator, text mining | PubMed |
| Time-regulated transcripts with the potential to modulate human pluripotent stem cell-derived cardiomyocyte differentiation. | Stem Cell Res Ther | 2022 | 36056380 | PubTator, text mining | PubMed |
| Genome scanning of behavioral selection in a canine olfactory detection breeding cohort. | Sci Rep | 2022 | 36056154 | PubTator, text mining | PubMed |
| Acute flaccid paralysis in Indonesian adult due to suspected familial hypokalemia paralysis: A rare case. | Ann Med Surg (Lond) | 2022 | 36045796 | PubTator, text mining | PubMed |
| Challenges and innovation: Disease modeling using human-induced pluripotent stem cell-derived cardiomyocytes. | Front Cardiovasc Med | 2022 | 36035948 | PubTator, text mining | PubMed |
| Clinical implications of the biomechanics of bicuspid aortic valve and bicuspid aortopathy. | Front Cardiovasc Med | 2022 | 36035900 | PubTator, text mining | PubMed |
| Circulating microRNA: Myocardium-derived prenatal biomarker of ventricular septal defects. | Front Genet | 2022 | 36035156 | PubTator, text mining | PubMed |
| Meta-Data Analysis to Explore the Hub of the Hub-Genes That Influence SARS-CoV-2 Infections Highlighting Their Pathogenetic Processes and Drugs Repurposing. | Vaccines (Basel) | 2022 | 36016137 | PubTator, text mining | PubMed |
| Genetic Analysis of Cardiac Syncope-Related Genes in Korean Patients with Recurrent Neurally Mediated Syncope. | J Cardiovasc Dev Dis | 2022 | 36005429 | PubTator, text mining | PubMed |
| Strategies to improve the therapeutic effect of pluripotent stem cell-derived cardiomyocytes on myocardial infarction. | Front Bioeng Biotechnol | 2022 | 35992358 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3759/papers?page=28